Table 3.
Marker | Valiathan et al. | Chgn et al. |
---|---|---|
CD3 | 65 – 88 | 47 – 79 |
CD19 | 2 – 27 | 7 – 22 |
CD4 | 26 – 62 | 23 – 47 |
CD8 | 14 – 44 | 14 – 40 |
NK | 2 – 27 | 7 – 37 |
CD4/CD8 ratio | 0.6 – 4.4 | 0.68 – 2.73 |
Marker | Valiathan et al. | Chgn et al. |
---|---|---|
CD3 | 65 – 88 | 47 – 79 |
CD19 | 2 – 27 | 7 – 22 |
CD4 | 26 – 62 | 23 – 47 |
CD8 | 14 – 44 | 14 – 40 |
NK | 2 – 27 | 7 – 37 |
CD4/CD8 ratio | 0.6 – 4.4 | 0.68 – 2.73 |